By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Onconova Therapeutics Inc. 

P.O. Box 7693

Princeton  New Jersey  08543  U.S.A.
Phone: 609-844-7735 Fax:


SEARCH JOBS








Company News
Onconova Therapeutics Inc. (ONTX) Reports Recent Business Highlights And First Quarter 2015 Financial Results 5/15/2015 8:32:54 AM
Onconova Therapeutics Inc. (ONTX) Announces Multiple Rigosertib Clinical Data Presentations At The 2015 ASCO Annual Meeting 5/14/2015 1:00:43 PM
Onconova Therapeutics Inc. (ONTX) Presenting Nine Abstracts Related To Rigosertib At The 13th International Symposium On Myelodysplastic Syndromes (MDS) 5/1/2015 10:23:49 AM
Onconova Therapeutics Inc. (ONTX) Highlights Rigosertib And Early-Stage Programs At The 2015 AACR Annual Meeting 4/21/2015 4:45:39 PM
Onconova Therapeutics Inc. (ONTX) Submits Pivotal Clinical Trial Protocol For IV Rigosertib In Higher-Risk Myelodysplastic Syndromes To FDA And European Medicines Agency 4/20/2015 8:04:34 AM
Onconova Therapeutics Inc. (ONTX) To Present New Data On Rigosertib And Earlier-Stage Programs At The 2015 American Association for Cancer Research Annual Meeting 4/7/2015 7:27:56 AM
Onconova Therapeutics Inc. (ONTX) Reports Recent Business Highlights And Fourth Quarter And Year-End 2014 Financial Results 3/27/2015 6:26:50 AM
Onconova Therapeutics Inc. (ONTX) To Present At 27th Annual ROTH Conference 3/4/2015 8:49:39 AM
Onconova Therapeutics Inc. (ONTX) Announces Clinical Development Plan For Rigosertib In Higher Risk Myelodysplastic Syndrome (HR-MDS) Patients After Failure Of Treatment With Hypomethylating Agents (Hmas) 2/3/2015 7:35:28 AM
Onconova Therapeutics Inc. (ONTX) To Present At Upcoming Investor Conferences In February 1/30/2015 7:45:54 AM
1234567
//-->